McCamish Mark Anthony
Insider CIK 1390798 · AVDL Director · FTSV President and CEO, Director · RFL Director · VINC Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| AVDL AVADEL PHARMACEUTICALS PLC | D To issuer deriv | 2026-02-12 | 2026-02-12 | 11,000 | — | $0 | 0 | SEC↗ |
| AVDL AVADEL PHARMACEUTICALS PLC | D To issuer deriv | 2026-02-12 | 2026-02-12 | 33,000 | — | $0 | 0 | SEC↗ |
| AVDL AVADEL PHARMACEUTICALS PLC | D To issuer deriv | 2026-02-12 | 2026-02-12 | 11,000 | — | $0 | 0 | SEC↗ |
| AVDL AVADEL PHARMACEUTICALS PLC | D To issuer deriv | 2026-02-12 | 2026-02-12 | 42,000 | — | $0 | 0 | SEC↗ |
| AVDL AVADEL PHARMACEUTICALS PLC | D To issuer deriv | 2026-02-12 | 2026-02-12 | 42,000 | — | $0 | 0 | SEC↗ |
| AVDL AVADEL PHARMACEUTICALS PLC | D To issuer deriv | 2026-02-12 | 2026-02-12 | 50,000 | — | $0 | 0 | SEC↗ |
| AVDL AVADEL PHARMACEUTICALS PLC | D To issuer deriv | 2026-02-12 | 2026-02-12 | 42,000 | — | $0 | 0 | SEC↗ |
| AVDL AVADEL PHARMACEUTICALS PLC | D To issuer deriv | 2026-02-12 | 2026-02-12 | 60,000 | — | $0 | 0 | SEC↗ |
| AVDL AVADEL PHARMACEUTICALS PLC | D To issuer | 2026-02-12 | 2026-02-12 | 22,000 | $21.00 | $462.0K | 0 | SEC↗ |
| AVDL AVADEL PHARMACEUTICALS PLC | D To issuer | 2026-02-12 | 2026-02-12 | 67,025 | $21.00 | $1.41M | 0 | SEC↗ |
| AVDL AVADEL PHARMACEUTICALS PLC | G Gift | 2026-02-04 | 2026-02-06 | 67,025 | — | $0 | 0 | SEC↗ |
| AVDL AVADEL PHARMACEUTICALS PLC | G Gift | 2026-02-04 | 2026-02-06 | 67,025 | — | $0 | 67,025 | SEC↗ |
| AVDL AVADEL PHARMACEUTICALS PLC | A Award deriv | 2025-07-29 | 2025-07-31 | 11,000 | — | $0 | 11,000 | SEC↗ |
| AVDL AVADEL PHARMACEUTICALS PLC | A Award | 2025-07-29 | 2025-07-31 | 11,000 | — | $0 | 22,000 | SEC↗ |
| AVDL AVADEL PHARMACEUTICALS PLC | A Award deriv | 2024-07-30 | 2024-08-01 | 11,000 | — | $0 | 11,000 | SEC↗ |
| AVDL AVADEL PHARMACEUTICALS PLC | A Award | 2024-07-30 | 2024-08-01 | 11,000 | — | $0 | 11,000 | SEC↗ |
| RFL Rafael Holdings, Inc. | A Award | 2024-01-05 | 2024-01-08 | 27,655 | $1.81 | $50.1K | 60,241 | SEC↗ |
| AVDL AVADEL PHARMACEUTICALS PLC | S Sale | 2023-12-28 | 2023-12-29 | 75,000 | $14.53 | $1.09M | 67,025 | SEC↗ |
| AVDL AVADEL PHARMACEUTICALS PLC | S Sale | 2023-08-11 | 2023-08-15 | 28,975 | $14.93 | $432.6K | 142,025 | SEC↗ |
| AVDL AVADEL PHARMACEUTICALS PLC | A Award deriv | 2023-08-01 | 2023-08-03 | 33,000 | — | $0 | 33,000 | SEC↗ |
| RFL Rafael Holdings, Inc. | A Award | 2023-01-05 | 2023-01-05 | 27,174 | $1.84 | $50.0K | 32,586 | SEC↗ |
| AVDL AVADEL PHARMACEUTICALS PLC | A Award deriv | 2022-08-03 | 2022-08-05 | 42,000 | — | $0 | 42,000 | SEC↗ |
| RFL Rafael Holdings, Inc. | A Award | 2022-01-05 | 2022-01-05 | 5,412 | $5.39 | $29.2K | 5,412 | SEC↗ |
| AVDL AVADEL PHARMACEUTICALS PLC | A Award deriv | 2021-08-03 | 2021-08-05 | 42,000 | — | $0 | 42,000 | SEC↗ |
| VINC Vincera Pharma, Inc. | A Award deriv | 2020-12-23 | 2020-12-28 | 6,667 | — | $0 | 6,667 | SEC↗ |
| AVDL AVADEL PHARMACEUTICALS PLC | P Buy | 2020-09-17 | 2020-09-18 | 52,398 | $5.83 | $305.5K | 171,000 | SEC↗ |
| AVDL AVADEL PHARMACEUTICALS PLC | P Buy | 2020-09-16 | 2020-09-18 | 118,602 | $5.73 | $679.6K | 118,602 | SEC↗ |
| AVDL AVADEL PHARMACEUTICALS PLC | A Award deriv | 2020-09-13 | 2020-09-14 | 50,000 | — | $0 | 50,000 | SEC↗ |
| AVDL AVADEL PHARMACEUTICALS PLC | A Award deriv | 2020-08-07 | 2020-08-11 | 42,000 | — | $0 | 42,000 | SEC↗ |
| FTSV Forty Seven, Inc. | D To issuer deriv | 2020-04-07 | 2020-04-07 | 184,516 | — | $0 | 0 | SEC↗ |
| FTSV Forty Seven, Inc. | D To issuer deriv | 2020-04-07 | 2020-04-07 | 327,375 | — | $0 | 0 | SEC↗ |
| FTSV Forty Seven, Inc. | D To issuer deriv | 2020-04-07 | 2020-04-07 | 334,239 | — | $0 | 0 | SEC↗ |
| FTSV Forty Seven, Inc. | D To issuer deriv | 2020-04-07 | 2020-04-07 | 134,629 | — | $0 | 0 | SEC↗ |
| FTSV Forty Seven, Inc. | D To issuer deriv | 2020-04-07 | 2020-04-07 | 314,395 | — | $0 | 0 | SEC↗ |
| FTSV Forty Seven, Inc. | D To issuer | 2020-04-07 | 2020-04-07 | 4,595 | — | $0 | 0 | SEC↗ |
| FTSV Forty Seven, Inc. | M Exercise deriv | 2020-04-01 | 2020-04-03 | 30,210 | — | $0 | 314,395 | SEC↗ |
| FTSV Forty Seven, Inc. | M Exercise deriv | 2020-04-01 | 2020-04-03 | 27 | — | $0 | 134,629 | SEC↗ |
| FTSV Forty Seven, Inc. | S Sale | 2020-04-01 | 2020-04-03 | 30,237 | $95.42 | $2.89M | 4,595 | SEC↗ |
| FTSV Forty Seven, Inc. | S Sale | 2020-04-01 | 2020-04-03 | 2,340 | $95.41 | $223.3K | 34,832 | SEC↗ |
| FTSV Forty Seven, Inc. | M Exercise | 2020-04-01 | 2020-04-03 | 30,237 | $4.88 | $147.6K | 37,172 | SEC↗ |
| FTSV Forty Seven, Inc. | G Gift | 2020-03-16 | 2020-04-03 | 60,719 | — | $0 | 0 | SEC↗ |
| FTSV Forty Seven, Inc. | A Award deriv | 2019-12-13 | 2019-12-17 | 327,375 | — | $0 | 327,375 | SEC↗ |
| AVDL AVADEL PHARMACEUTICALS PLC | A Award deriv | 2019-12-05 | 2019-12-09 | 60,000 | — | $0 | 60,000 | SEC↗ |
| FTSV Forty Seven, Inc. | M Exercise deriv | 2019-06-25 | 2019-06-27 | 8,199 | — | $0 | 344,605 | SEC↗ |
| FTSV Forty Seven, Inc. | M Exercise | 2019-06-25 | 2019-06-27 | 8,199 | $4.88 | $40.0K | 68,918 | SEC↗ |
| FTSV Forty Seven, Inc. | S Sale | 2019-06-25 | 2019-06-27 | 8,199 | $11.02 | $90.4K | 60,719 | SEC↗ |
| FTSV Forty Seven, Inc. | M Exercise deriv | 2019-06-20 | 2019-06-24 | 8,301 | — | $0 | 352,804 | SEC↗ |
| FTSV Forty Seven, Inc. | S Sale | 2019-06-20 | 2019-06-24 | 8,301 | $11.04 | $91.6K | 60,719 | SEC↗ |
| FTSV Forty Seven, Inc. | M Exercise | 2019-06-20 | 2019-06-24 | 8,301 | $4.88 | $40.5K | 69,020 | SEC↗ |
| FTSV Forty Seven, Inc. | M Exercise deriv | 2019-05-20 | 2019-05-22 | 15,209 | — | $0 | 362,396 | SEC↗ |
| FTSV Forty Seven, Inc. | M Exercise deriv | 2019-05-20 | 2019-05-22 | 1,291 | — | $0 | 361,105 | SEC↗ |
| FTSV Forty Seven, Inc. | S Sale | 2019-05-20 | 2019-05-22 | 1,291 | $12.46 | $16.1K | 60,719 | SEC↗ |
| FTSV Forty Seven, Inc. | M Exercise | 2019-05-20 | 2019-05-22 | 1,291 | $4.88 | $6.3K | 62,010 | SEC↗ |
| FTSV Forty Seven, Inc. | S Sale | 2019-05-20 | 2019-05-22 | 15,209 | $12.07 | $183.6K | 60,719 | SEC↗ |
| FTSV Forty Seven, Inc. | M Exercise | 2019-05-20 | 2019-05-22 | 15,209 | $4.88 | $74.2K | 75,928 | SEC↗ |
| FTSV Forty Seven, Inc. | M Exercise deriv | 2019-04-18 | 2019-04-22 | 16,500 | — | $0 | 377,605 | SEC↗ |
| FTSV Forty Seven, Inc. | M Exercise | 2019-04-18 | 2019-04-22 | 16,500 | $4.88 | $80.5K | 77,219 | SEC↗ |
| FTSV Forty Seven, Inc. | S Sale | 2019-04-18 | 2019-04-22 | 16,500 | $18.12 | $299.0K | 60,719 | SEC↗ |
| FTSV Forty Seven, Inc. | M Exercise deriv | 2019-03-19 | 2019-03-21 | 16,500 | — | $0 | 394,105 | SEC↗ |
| FTSV Forty Seven, Inc. | M Exercise | 2019-03-19 | 2019-03-21 | 16,500 | $4.88 | $80.5K | 77,219 | SEC↗ |
| FTSV Forty Seven, Inc. | S Sale | 2019-03-19 | 2019-03-21 | 16,500 | $18.15 | $299.5K | 60,719 | SEC↗ |
| FTSV Forty Seven, Inc. | M Exercise deriv | 2019-02-20 | 2019-02-21 | 9,410 | — | $0 | 410,605 | SEC↗ |
| FTSV Forty Seven, Inc. | S Sale | 2019-02-20 | 2019-02-21 | 9,410 | $14.94 | $140.6K | 60,719 | SEC↗ |
| FTSV Forty Seven, Inc. | M Exercise | 2019-02-20 | 2019-02-21 | 9,410 | $4.88 | $45.9K | 70,129 | SEC↗ |
| FTSV Forty Seven, Inc. | M Exercise deriv | 2019-02-19 | 2019-02-21 | 7,090 | — | $0 | 420,015 | SEC↗ |
| FTSV Forty Seven, Inc. | S Sale | 2019-02-19 | 2019-02-21 | 7,090 | $15.06 | $106.8K | 60,719 | SEC↗ |
| FTSV Forty Seven, Inc. | M Exercise | 2019-02-19 | 2019-02-21 | 7,090 | $4.88 | $34.6K | 67,809 | SEC↗ |
| FTSV Forty Seven, Inc. | M Exercise deriv | 2019-01-25 | 2019-01-29 | 31,233 | — | $0 | 427,105 | SEC↗ |
| FTSV Forty Seven, Inc. | M Exercise deriv | 2019-01-25 | 2019-01-29 | 20,454 | — | $0 | 134,656 | SEC↗ |
| FTSV Forty Seven, Inc. | M Exercise | 2019-01-25 | 2019-01-29 | 20,454 | $4.88 | $99.8K | 60,719 | SEC↗ |
| FTSV Forty Seven, Inc. | M Exercise | 2019-01-25 | 2019-01-29 | 31,233 | $4.88 | $152.4K | 40,265 | SEC↗ |
| FTSV Forty Seven, Inc. | M Exercise deriv | 2019-01-18 | 2019-01-23 | 3,500 | — | $0 | 155,110 | SEC↗ |
| FTSV Forty Seven, Inc. | M Exercise deriv | 2019-01-18 | 2019-01-23 | 16,500 | — | $0 | 458,338 | SEC↗ |
| FTSV Forty Seven, Inc. | S Sale | 2019-01-18 | 2019-01-23 | 20,000 | $14.59 | $291.8K | 9,032 | SEC↗ |
| FTSV Forty Seven, Inc. | M Exercise | 2019-01-18 | 2019-01-23 | 16,500 | $4.88 | $80.5K | 25,532 | SEC↗ |
| FTSV Forty Seven, Inc. | M Exercise | 2019-01-18 | 2019-01-23 | 3,500 | $4.88 | $17.1K | 29,032 | SEC↗ |
| FTSV Forty Seven, Inc. | M Exercise deriv | 2018-12-26 | 2018-12-28 | 9,032 | — | $0 | 474,838 | SEC↗ |
| FTSV Forty Seven, Inc. | M Exercise deriv | 2018-12-26 | 2018-12-28 | 2,968 | — | $0 | 158,610 | SEC↗ |
| FTSV Forty Seven, Inc. | M Exercise | 2018-12-26 | 2018-12-28 | 9,032 | $4.88 | $44.1K | 18,064 | SEC↗ |
| FTSV Forty Seven, Inc. | S Sale | 2018-12-26 | 2018-12-28 | 2,968 | $15.89 | $47.2K | 9,032 | SEC↗ |
| FTSV Forty Seven, Inc. | M Exercise | 2018-12-26 | 2018-12-28 | 2,968 | $4.88 | $14.5K | 21,032 | SEC↗ |
| FTSV Forty Seven, Inc. | S Sale | 2018-12-26 | 2018-12-28 | 9,032 | $15.90 | $143.6K | 12,000 | SEC↗ |